385
Views
15
CrossRef citations to date
0
Altmetric
Editorial

Development of preeclampsia provides a window of opportunity for early cardiovascular risk screening and intervention

Pages 355-357 | Published online: 10 Jan 2014

References

  • Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. BMJ335, 974 (2007).
  • Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet357, 2002–2006 (2001).
  • Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet366, 1797–1803 (2005).
  • Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study. Paediatr. Perinat. Epidemiol.19, 59–68 (2005).
  • Manten GTR, Sikkema MJ, Voorbij HAM, Visser GHA, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens. Pregnancy26, 39–50 (2007).
  • Forest J-C, Girouard J, Masse J et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet. Gynecol.105, 1373–1380 (2005).
  • Smith GN, Walker M, Liu A et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am. J. Obstet. Gynecol.200, 58.e1–58.e8 (2009).
  • Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome in pregnancy? Atherosclerosis175, 189–202 (2004).
  • Roberts JM, Gammill H. Preeclampsia: recent insights. Hypertension46, 1243–1249 (2005).
  • Ray JG. Metabolic syndrome and higher risk of maternal placental syndromes and cardiovascular disease. Drug Dev. Res.67, 1–5 (2006).
  • Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta23, 359–372 (2002).
  • Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta30, 32–37 (2009).
  • Williams D. Pregnancy: a stress test for life. Curr. Opin. Obstet. Gynecol.15, 465–471 (2003).
  • Irgens HU, Reisaeter L, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ323, 1213–1217 (2001).
  • Roberts JM, Gammill H. Pre-eclampsia and cardiovascular disease in later life. Lancet366, 961–962 (2005).
  • Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Smith GD, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ335, 978 (2007).
  • Parretti E, Lapolla A, Dalfra MG et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension47, 449–453 (2006).
  • Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet. Gynecol.94, 543–550 (1999).
  • Ramsay JE, Ferrell WR, Crawford L, Wallace EM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J. Clin. Endocrinol. Metab.87(4231), 4237 (2002).
  • Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am. J. Med. Sci.334, 291–295 (2007).
  • Bar J, Kaplan B, Wittenberg C et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol. Dial. Transplant.14, 1129–1132 (1999).
  • North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following pregnancy. Aust. NZ J. Obstet. Gynaecol.36, 233–238 (1996).
  • Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairement of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am. J. Physiol. Circ. Physiol.286, H1389–H1393 (2004).
  • Ronnback M, Lampinen K, Groop P-H, Kaaja R. Pulse wave reflection in currently and previously preeclamptic women. Hypertens. Pregnancy24, 171–180 (2005).
  • Mosca L, Banka CL, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation115, 1481–1501 (2007).
  • Tu K, Chen Z, Lipscombe LL; Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ178, 1429–1435 (2008).
  • Leenen FHH, Dumais J, McInnis NH et al. Results of the Ontario Survey on the prevalence and control of hypertension. CMAJ178, 1441–1449 (2008).
  • MacDonald S, Smith GN, Godwin M, Walker M, Chen XK, Ramshaw H. Survey of obstetrical care providers understanding of long term risks and follow up of women with hypertensive disorders in pregnancy. J. Obstet. Gynaecol. Can.29, 705–710 (2007).
  • Mosca L, Lindante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines in the United States. Circulation111, 499–510 (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.